CANCER DRUG DISCOVERY: DIVERSITY GENERATION AND SMART ASSAYS -ADDENDUM
 
NIH GUIDE, Volume 26, Number 22, June 27, 1997
 
RFA:  CA-97-006
 
P.T. 34

Keywords:
  Cancer/Carcinogenesis 
  Chemistry, Organic 
  Medicinal Chemistry 
  Chemotherapeutic Agents 
  Drug Design 
 
National Cancer Institute
 
The following additional information is provided for RFA CA-97-006,
"Cancer Drug Discovery: Diversity Generation and Smart Assays," which
appeared in the NIH Guide, Vol. 26, No. 15, May 9, 1997:
 
The Letter of Intent Receipt Date has been changed to July 11, 1997.
The Application Receipt Date remains at August 22, 1997.
 
The following section on FUNDS AVAILABLE has been changed to clarify
the budget limitations on applications.
 
The NCI has set aside $3.75 million total costs (direct plus
facilities and administrative costs) for the first year of funding.
The number of awards and level of support is dependent on the receipt
of a sufficient number and diversity of applications with high
scientific merit.  It is expected that most awards will not exceed
$950,000 total costs (direct plus facilities and administrative
costs) for year one with no more than a 3% per year increase for
future years.  Exceptionally meritorious applications may be funded
at a higher level provided the budget is adequately justified and
considered reasonable by peer review.  In all cases, budget requests
should be carefully justified and commensurate with the needs of the
project.  Because the nature and scope of the research proposed in
response to the RFA may vary, it is anticipated that the size of the
awards may vary.  It is anticipated that four to five awards will be
made for periods up to five years, with the earliest expected award
date being April 1, 1998.
 
Although this program is provided for in the financial plans of the
NCI, awards pursuant to this RFA are contingent upon the availability
of funds for this purpose.
 
INQUIRIES
 
For further information contact:
 
Mary K. Wolpert, Ph.D.
Division of Cancer Treatment, Diagnosis and Centers
National Cancer Institute
6130 Executive Boulevard, Room 841, MSC 7456
Bethesda, MD  20892-7456
Telephone:  (301) 496-8783
FAX:  (301) 402-5200
Email:  wolpertm@dtpepn.nci.nih.gov
 


Return to 1997 Index

Return to NIH Guide Main Index


Office of Extramural Research (OER) - Home Page Office of Extramural
Research (OER)
  National Institutes of Health (NIH) - Home Page National Institutes of Health (NIH)
9000 Rockville Pike
Bethesda, Maryland 20892
  Department of Health and Human Services (HHS) - Home Page Department of Health
and Human Services (HHS)
  USA.gov - Government Made Easy


Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.